RSS03.12 Preclinical Drug Discovery

Course is confirmed

The course will be organized jointly by Radboud University (Nijmegen), Pivot Park Life Science campus (Oss) and HAN University of Applied Sciences (Nijmegen), covering the most important aspects of modern drug discovery.

A selection of the following subjects will be covered during the course:

  • principles and challenges of drug discovery,
  • different phases of drug discovery,
  • conventional and novel therapeutic modalities,
  • target identification and validation,
  • assay development and hit finding through high-throughput screening,
  • importance of hit triaging and validation of target engagement,
  • medicinal chemistry and hit & lead optimization,
  • ADMET, animal PoC,
  • Chemistry Manufacturing and Controls
  • Regulatory affairs
  • IP generation and
  • clinical studies.

The content of the lectures are designed by academic and industry experts in the field of early drug discovery and the course is a combination of lectures, seminars, group assignments and visits to companies active in pharmaceutical R&D located on Pivot Park Life Science Campus.


3 July 2023 - 7 July 2023
Course Fee

Regular: €650

Early Bird: €585 (application deadline* April 1st)

Scholarships and discounts

Find more information here

If you'll be attending this course with an Erasmus+ scholarship, you need to visit the Radboud University in Nijmegen on Monday morning first.

Application deadline

June 1st

*Your application is only completed when the course fee has been paid

Course leader
Level of participant
  • Advanced Bachelor
  • Master
  • Professionals in health care
Admission requirements None
Admission documents
  • Motivation letter
  • CV
Mode of Study On Campus Oss
Location Pivot Park in Oss